Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: MHRA Approves Olezarsen For Treatment Of Familial Chylomicronemia Syndrome

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    10/04/2026 16:05
    April 10 (Reuters) - MHRA:

MHRA: APPROVES OLEZARSEN (TRYNGOLZA) FOR THE TREATMENT OF FAMILIAL CHYLOMICRONEMIA SYNDROME

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news